Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE   US3632561086

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/28/2015 04/29/2015 04/30/2015 05/01/2015 05/04/2015 Date
1.37(c) 1.37(c) 1.35(c) 1.37(c) 1.39(c) Last
2 752 644 1 309 110 2 255 930 1 334 412 899 572 Volume
-2.14% -0.00% -1.46% +1.48% +1.46% Change
More quotes
Financials ($)
Sales 2015 16,5 M
EBIT 2015 -45,6 M
Net income 2015 -41,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 26,5 M
EBIT 2016 -38,5 M
Net income 2016 -36,7 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 13,6x
Capi. / Sales 2016 8,49x
Capitalization 225 M
More Financials
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.It currently develops peptide antigenbased off the shelf cancer immunotherapies for... 
Sector
Pharmaceuticals
Calendar
05/07Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
04/25 GALENA BIOPHARMA : Notice of Summons and Complaint Against Defendants Milla Bjor..
04/23 GALENA BIOPHARMA : to Report First Quarter Financial Results on Thursday, May 7,..
04/23 Galena Biopharma to Report First Quarter Financial Results on Thursday, May 7..
04/18 GALENA BIOPHARMA : Notice of Summons and Complaint Against Defendants Milla Bjor..
04/14 GALENA BIOPHARMA : Completes Over-Enrollment of NeuVax(TM) (nelipepimut-S) Phase..
04/14 Galena Biopharma Completes Over-Enrollment of NeuVax(TM) (nelipepimut-S) Phas..
04/11 GALENA BIOPHARMA : Notice of Summons and Complaint Against Defendants Milla Bjor..
04/10 Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total..
More news
Sector news : Pharmaceuticals - NEC
05:04a GRIFOLS : a healthcare company participates in White House Upskill Summit
05:04a BAYER : Makrolon® Silent Sound for noise protection barriers -- Transparent nois..
04:04a BAYER : Achieving customized automotive interiors easily and cost-effectively --..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/01 NEXT WEEK IN BIOTECH : Earnings Deluge - From GSK And Achillion To Intercept And..
04/24 SEEKING ALPHA'S BIOTECH WEEKLY : Gilead Isn't Perfect, Biogen-Bass, Spring Fever..
04/22 Galena Biopharma Is A Worthwhile Gamble For The Short Or Long Term
04/14 Galena completes over-enrollment in Phase 3 NeuVax study
04/10 SEEKING ALPHA'S BIOTECH WEEKLY : A Biogen Deep Dive, Eisai's Arena Shuffle, And ..


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF